Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

FRAXINUS EXCELSIOR DIN 02233145

Status: Cancelled Post Market
Holder: SEROYAL INTERNATIONAL INC.
Molecule: FRAXINUS EXCELSIOR

Health Canada record

Active ingredient(s)FRAXINUS EXCELSIOR 1 X
Dosage formPellet; Granules; Tablet; Drops; Globules; Liquid
RouteOral
ScheduleHOMEOPATHIC
ClassHuman
ATC
Original market date06-Apr-1998
Current status date06-Jul-2009
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing FRAXINUS EXCELSIOR

DINProductCompanyFormStrengthStatus
02233988FRAXINUS EXCELSIORHOMEOCAN INC.Globules; Drops; GranulesFRAXINUS EXCELSIOR 1 XCancelled Post Market
02234493FRAXINUS EXCELSIORDOLISOS CANADA INC.Globules; Liquid; GranulesFRAXINUS EXCELSIOR 1 XCancelled Post Market
01917994FRAXINUS EXCELSIOR GRANULE 1DH-30CHHOMEOCAN INC.TabletFRAXINUS EXCELSIOR 1 DHCancelled Post Market
Request a quote for FRAXINUS EXCELSIOR

How to read a Canadian DIN record